Questo prodotto usufruisce delle SPEDIZIONI GRATIS
selezionando l'opzione Corriere Veloce in fase di ordine.
Pagabile anche con Carta della cultura giovani e del merito, 18App Bonus Cultura e Carta del Docente
Introduction and History of the Chemistry of Nucleic Acids Therapeutics.- Antisense RNA Therapeutics: A Brief Overview.- Design of Bifunctional Antisense Oligonucleotides for Exon Inclusion.- Design and Delivery of SINEUP: A New Modular Tool to Increase Protein Translation.- How to Design U1 snRNA Molecules for Splicing Rescue.- Conjugation of Nucleic Acids and Drugs to Gold Nanoparticles.- Determination of Optimum Ratio of Cationic Polymers and Small Interfering RNA with Agarose Gel Retardation Assay.- Generation of Protein-Phosphorodiamidate Morpholino Oligomer Conjugates for Efficient Cellular Delivery via Anthrax Protective Antigen.- Development and Use of Cellular Systems to Assess and Correct Splicing Defects.- Modeling Splicing Variants Amenable to Antisense Therapy by Use of CRISPR-Cas9-Based Gene Editing in HepG2 Cells.- In Vitro Models for the Evaluation of Antisense Oligonucleotides in Skin.- In Vitro Delivery of PMOs in Myoblasts by Electroporation.- Rapid Determination of MBNL1 Protein Levels by Quantitative Dot Blot for Evaluation of Antisense Oligonucleotides in Myotonic Dystrophy Myoblasts.- Evaluation of Exon Skipping and Dystrophin Restoration in In Vitro Models of Duchenne Muscular Dystrophy.- Generation of Human iPSC-Derived Myotubes to Investigate RNA-Based Therapies In Vitro.- Eye on a Dish Models to Evaluate Splicing Modulation.- Establishment of In Vitro Brain Models for AON Delivery.- Considerations for Generating Humanized Mouse Models to Test Efficacy of Antisense Oligonucleotides.- Generation of Humanized Zebrafish Models for the In Vivo Assessment of Antisense Oligonucleotide-Based Splice Modulation Therapies.- Use of Small Animal Models for Duchenne and Parameters to Assess Efficiency upon Antisense Treatment.- In Vivo Models for the Evaluation of Antisense Oligonucleotides in Skin.- Delivery of Antisense Oligonucleotides to the Mouse Retina.- Delivery of Antisense Oligonucleotides to the Mouse Brain by Intracerebroventricular Injections.- Intrathecal Delivery of Therapeutic Oligonucleotides for Potent Modulation of Gene Expression in the Central Nervous System.- Preclinical Safety Assessment of Therapeutic Oligonucleotides.- Preclinical Evaluation of the Renal Toxicity of Oligonucleotide Therapeutics in Mice.- Protocol for Isolation and Culture of Mouse Hepatocytes (HCs), Kupffer Cells (KCs), and Liver Sinusoidal Endothelial Cells (LSECs) in Analyses of Hepatic Drug Distribution.- Patent Considerations When Embarking on New Antisense Drug Programs.
Il sito utilizza cookie ed altri strumenti di tracciamento che raccolgono informazioni dal dispositivo dell’utente. Oltre ai cookie tecnici ed analitici aggregati, strettamente necessari per il funzionamento di questo sito web, previo consenso dell’utente possono essere installati cookie di profilazione e marketing e cookie dei social media. Cliccando su “Accetto tutti i cookie” saranno attivate tutte le categorie di cookie. Per accettare solo deterninate categorie di cookie, cliccare invece su “Impostazioni cookie”. Chiudendo il banner o continuando a navigare saranno installati solo cookie tecnici. Per maggiori dettagli, consultare la Cookie Policy.